Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells.
Interferon-β is an established treatment for patients with multiple sclerosis (MS) but its mechanisms of action are not well understood. Viral infections are a known trigger of MS relapses. Toll-like receptors (TLRs) are key components of the innate immune system, which sense conserved structures of...
Main Authors: | Katja Derkow, Jakob M J Bauer, Michael Hecker, Brigitte K Paap, Madhan Thamilarasan, Dirk Koczan, Eckart Schott, Katrin Deuschle, Judith Bellmann-Strobl, Friedemann Paul, Uwe K Zettl, Klemens Ruprecht, Seija Lehnardt |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23950974/?tool=EBI |
Similar Items
-
Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
by: Katja Derkow, et al.
Published: (2015-01-01) -
Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists
by: Linda K. Curtiss, et al.
Published: (2012-10-01) -
Mast cell Toll-like receptors (TLR
by: Ewa Brzezińska-Błaszczyk, et al.
Published: (2010-02-01) -
Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists
by: Vasilakos John P, et al.
Published: (2007-10-01) -
Toll-like receptor (TLR2 and TLR4) polymorphisms and chronic obstructive pulmonary disease.
by: Simona E Budulac, et al.
Published: (2012-01-01)